SEC Form 4 · accession 0001179110-15-002987
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Smither
Officer — Chief Financial Officer
Period of report
Feb 17, 2015
Accepted (ET)
Feb 19, 2015 · 6:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 17, 2015 | S | 1,000 | $40.00 | D | 17,416 | I | See Footnote |
| Common StockF2 | Feb 18, 2015 | S | 1,000 | $42.00 | D | 16,416 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires January 22, 2016.
- F2Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees.